Advanced Cell Technology, Marlborough, MA 01752, USA.
Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612, USA.
Stem Cell Reports. 2014 Nov 11;3(5):817-31. doi: 10.1016/j.stemcr.2014.09.010. Epub 2014 Oct 16.
Human induced pluripotent stem cells (iPSCs) provide a potentially replenishable source for the production of transfusable platelets. Here, we describe a method to generate megakaryocytes (MKs) and functional platelets from iPSCs in a scalable manner under serum/feeder-free conditions. The method also permits the cryopreservation of MK progenitors, enabling a rapid "surge" capacity when large numbers of platelets are needed. Ultrastructural/morphological analyses show no major differences between iPSC platelets and human blood platelets. iPSC platelets form aggregates, lamellipodia, and filopodia after activation and circulate in macrophage-depleted animals and incorporate into developing mouse thrombi in a manner identical to human platelets. By knocking out the β2-microglobulin gene, we have generated platelets that are negative for the major histocompatibility antigens. The scalable generation of HLA-ABC-negative platelets from a renewable cell source represents an important step toward generating universal platelets for transfusion as well as a potential strategy for the management of platelet refractoriness.
人类诱导多能干细胞(iPSCs)为可输血血小板的生产提供了潜在的可再生来源。在这里,我们描述了一种在无血清/饲养层条件下可规模化生成巨核细胞(MKs)和功能血小板的方法。该方法还允许 MK 祖细胞的冷冻保存,当需要大量血小板时,可以快速“激增”。超微结构/形态分析显示,iPSC 血小板与人血血小板之间没有明显差异。iPSC 血小板在激活后形成聚集物、片状伪足和丝状伪足,并在巨噬细胞耗尽的动物中循环,并以与人血小板相同的方式整合到正在发育的小鼠血栓中。通过敲除β2-微球蛋白基因,我们生成了主要组织相容性抗原阴性的血小板。从可再生细胞来源规模化生成 HLA-ABC 阴性血小板,是朝着生产通用血小板用于输血以及管理血小板反应性降低迈出的重要一步。